Nikas, I.P.; Themistocleous, S.C.; Paschou, S.A.; Tsamis, K.I.; Ryu, H.S.
Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells 2020, 9, 19.
https://doi.org/10.3390/cells9010019
AMA Style
Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS.
Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells. 2020; 9(1):19.
https://doi.org/10.3390/cells9010019
Chicago/Turabian Style
Nikas, Ilias P., Sophie C. Themistocleous, Stavroula A. Paschou, Konstantinos I. Tsamis, and Han Suk Ryu.
2020. "Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives" Cells 9, no. 1: 19.
https://doi.org/10.3390/cells9010019
APA Style
Nikas, I. P., Themistocleous, S. C., Paschou, S. A., Tsamis, K. I., & Ryu, H. S.
(2020). Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells, 9(1), 19.
https://doi.org/10.3390/cells9010019